This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,907.70 firm fixed-price delivery order is for the supply of 4,566,690,209 capsules of the drug Vyvanse (40 mg), with an ultimate completion date of December 12, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order falls under that broader IDC. The contract does not have a set-aside designation, indicating open competition.
Generated 3/12/25, 9:59 AM